top of page
Strategists and Implementers
for growing companies globally
About FC Global
Management
Advisory Services
Cross-Border Strategjes
Our Approach
GDRs and ADRs
Our Process
Let's Have a Call
More...
Use tab to navigate through the menu items.
Subscribe to Our Newsletters
Contact Us
Disclaimer & DIsclosure
Recent Postings
May 26, 2024
4 min read
MedNews: Lilly increases its manufacturing investment in its newest Indiana site to $9 Billion to boost API production for Tirzepatide for weight loss and diabetes and its pipeline medicines
This investment represents the single largest investment in synthetic medicine API manufacturing in US history.
bottom of page
